Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan To Kick Off Public/Private Biotech Funding Venture

This article was originally published in PharmAsia News

Executive Summary

Taiwan plans to create a public-private biotechnology venture capital firm in an effort to build the industry as one of six the government has emphasized. The bioventure would receive 40 percent of its funds from the government, the rest to come from the private sector. The nation's Executive Yuan Council is earmarking up to $296 million in seed money for the first phase of the initiative. The five other industries, including pharmaceutical and healthcare industries, are to receive their own joint venture funding programs in the future. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel